05 Apr 2022 Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study Member news
05 Apr 2022 Aligos Therapeutics selects drug candidate ALG-097558, a potent ritonavir-free oral protease inhibitor for the treatment and prevention of COVID-19 Member news
29 Mar 2022 Rejuvenate Biomed started a groundbreaking clinical trial and expands for future growth Member news
22 Mar 2022 argenx announces positive topline Phase 3 data from ADAPT-SC study evaluating subcutaneous efgartigimod for generalized myasthenia gravis Member news
10 Mar 2022 Confo Therapeutics doses first subjects in Phase 1 clinical trial of CFTX-1554 for the treatment of neuropathic pain Member news
17 Feb 2022 miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study Member news
04 Feb 2022 UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results Member news
25 Jan 2022 Large UK study shows rapid EGFR testing with Idylla™ alongside NGS has potential to enhance lung cancer patient health outcomes Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
